GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 62.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,445 shares of the company's stock after buying an additional 21,997 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in GE HealthCare Technologies were worth $4,491,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC raised its position in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies during the third quarter worth approximately $26,000. Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC boosted its holdings in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after buying an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded down $0.58 during trading hours on Tuesday, reaching $86.93. 2,488,015 shares of the company's stock were exchanged, compared to its average volume of 2,666,542. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company's 50 day moving average is $83.06 and its two-hundred day moving average is $85.13. The company has a market cap of $39.72 billion, a P/E ratio of 23.88, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14. GE HealthCare Technologies Inc. has a 1 year low of $72.61 and a 1 year high of $94.55.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.85%.

Analyst Ratings Changes

A number of brokerages recently weighed in on GEHC. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $96.00.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.27% of the company's stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.